Reference
Rattanachotphanit, et al. Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding. PharmacoEconomics : 2 Nov 2018. Available from: URL: https://doi.org/10.1007/s40273-018-0741-3
Rights and permissions
About this article
Cite this article
Edoxaban recommended for stroke prevention in AF in Thailand. PharmacoEcon Outcomes News 816, 13 (2018). https://doi.org/10.1007/s40274-018-5433-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5433-x